Vera Therapeutics VERA Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Vera Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's quick ratio?
- Vera Therapeutics (VERA) reported quick ratio of 13.6× in Q1 2026.
- How has Vera Therapeutics's quick ratio changed year-over-year?
- Vera Therapeutics's quick ratio decreased by 50.7% year-over-year, from 27.7× to 13.6×.
- What is the long-term trend for Vera Therapeutics's quick ratio?
- Over 5 years (2020 to 2025), Vera Therapeutics's quick ratio has grown at a -9.6% compound annual growth rate (CAGR), from 22.6× to 13.6×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.